Williams v. Mast Biosurgery USA, Inc.

644 F.3d 1312, 85 Fed. R. Serv. 952, 2011 U.S. App. LEXIS 13362, 2011 WL 2566426
CourtCourt of Appeals for the Eleventh Circuit
DecidedJune 30, 2011
Docket10-12578
StatusPublished
Cited by76 cases

This text of 644 F.3d 1312 (Williams v. Mast Biosurgery USA, Inc.) is published on Counsel Stack Legal Research, covering Court of Appeals for the Eleventh Circuit primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Williams v. Mast Biosurgery USA, Inc., 644 F.3d 1312, 85 Fed. R. Serv. 952, 2011 U.S. App. LEXIS 13362, 2011 WL 2566426 (11th Cir. 2011).

Opinion

RIPPLE, Circuit Judge:

Wanda Williams brought this diversity action in the United States District Court for the Middle District of Georgia against Mast Biosurgery USA, Inc. (“Mast”), a medical device manufacturer. She sought relief under Georgia products liability law. After barring certain testimony that Ms. Williams had attempted to offer in order to establish an element of her claim, the district court entered summary judgment for Mast. We conclude that the district court did not err in its evidentiary rulings and that Ms. Williams has failed to introduce evidence sufficient to establish the manufacturing defect that she alleged. Accordingly, we affirm the judgment of the district court.

I

BACKGROUND

A. Facts

In 2006, Ms. Williams sought treatment for a painful, undiagnosed gynecological condition that was suspected to contribute to infertility. An ultrasound revealed a large ovarian cyst. Ms. Williams underwent a laproscopic procedure to drain the *1314 cyst. During the procedure, Dr. Adcock, her gynecologist, observed within Ms. Williams’s abdomen significant dense adhesions that had resulted from a prior surgery some years before. He further observed that these adhesions “were suspicious for malignancy or something to that effect.” R.37, Ex. 1 at 48.

To address further these observations, Dr. Adcock performed an exploratory laparotomy on August 22, 2006. During this second procedure, he biopsied Ms. Williams’s peritoneum and both ovaries and removed “extensive adhesions of [the] sigmoid and rectum to the posterior uterine fundus.” Id. at 49 (internal quotation marks omitted). To prevent new adhesions from forming, Dr. Adcock placed four pieces of SurgiWrap in Ms. Williams’s abdomen. SurgiWrap is a product designed and produced by Mast. It is marketed as a bioresorbable barrier used to prevent post-surgical adhesions. Dr. Ad-cock believed that preventing further adhesions between Ms. Williams’s organs could have a positive effect on her fertility.

One month after the August 22 procedure, Ms. Williams returned to Dr. Ad-cock’s office. She presented a number of symptoms, including persistent diarrhea, fever and pain in the lower left quadrant of her abdomen. Observing that she “looked really sick,” Dr. Adcock admitted her to the hospital and ordered tests to ascertain the reason for her distress. Id. at 81. After ruling out various causes of her symptoms, he referred her to Dr. George Yared, a gastroenterologist, for a colonoscopy. During the colonoscopy, Dr. Yared observed what he described as several stiff, hard and brittle pieces of plastic in Ms. Williams’s colon, some as large as fourteen to eighteen millimeters. He removed two large pieces, but was unable to remove other pieces embedded in the wall of the colon. He suspected the material was the SurgiWrap used by Dr. Adcock during the August 22 procedure.' The day following the colonoscopy, Ms. Williams underwent, at Dr. Yared’s recommendation, a further exploratory procedure by Dr. Robert Brown, a general surgeon. In addition to cleaning out the significant infection in her pelvis, Dr. Brown performed a partial sigmoid colectomy to remove a damaged section of her colon, an appendectomy and a colostomy formation. He found and removed multiple small pieces that he believed were a foreign, clear, plastic-like substance. A pathologist, Dr. Robert Nelms, Jr., examined the specimens and described the material as stiff and thick.

The foreign bodies removed from Ms. Williams were not subjected to any chemical or other testing to determine their identity or composition.

B. District Court Proceedings

Ms. Williams filed a complaint against Mast seeking damages for her injuries on a strict products liability claim. She contended that the SurgiWrap used in her procedure had a manufacturing defect that caused it to perform in a manner other than as intended.

1. Evidentiary Matters

During discovery, Mast moved to exclude certain testimony offered by Ms. Williams’s treating physicians. It contended that they could not serve as experts. Preferring to wait until the depositions of the treating physicians had been taken, the court declined to rule on the motion. Mast therefore renewed its motion after the depositions were taken. It argued both that Ms. Williams had failed to abide by the procedural rules regarding expert designation and that the testimony failed to meet the standards established in Daubert v. Merrell Dow Pharmaceuticals, Inc., 509 U.S. 579, 113 S.Ct. 2786, 125 L.Ed.2d 469 (1993). Finally, Mast filed a motion for summary judgment, contending *1315 that Ms. Williams had not produced any admissible evidence that the SurgiWrap suffered from any manufacturing defect or that SurgiWrap was the cause of any injury to her.

The district court first granted in part and denied in part the motion to exclude testimony. The court evaluated the deposition of each physician independently, first to determine whether the testimony was lay or expert and then, if expert, to determine whether it was admissible under Daubert.

As to Dr. Adcock, the court ruled that he had offered admissible lay testimony regarding Ms. Williams’s condition and his treatment of her. It then concluded that Dr. Adcock’s further statements that, in his opinion, SurgiWrap had not dissolved as it was supposed to do and had instead become hardened shards of plastic were expert opinions. The court explained that it had “serious doubts,” R.52 at 5, regarding whether Dr. Adcock was qualified to offer an opinion on this matter, given his limited experience with the product, his admissions that he had not reviewed medical literature about it or conducted any tests, and his lack of expertise in plastics generally. Nevertheless, the court considered whether his testimony would be reliable and concluded that it would not. The court, therefore, barred Dr. Adcock’s proffered testimony that SurgiWrap did not perform as intended and instead had hardened. It also refused to allow his testimony that the material removed from Ms. Williams was SurgiWrap.

Turning to the testimony of Dr. Yared, the district court concluded that he too would offer a mix of lay and expert testimony. However, the court ruled that Dr. Yared’s expert opinion that Ms. Williams’s injuries were caused by the foreign bodies he had removed was admissible. Unlike Dr. Adcock, Dr. Yared had followed an established methodology, differential diagnosis, to arrive at his conclusion about causation. Using this method, he had considered numerous potential causes of the fistula, ruled out all but the foreign body and “ruled in” the foreign body as a potential cause. Id. at 11. Accordingly, Dr. Yared was permitted to testify not only about his observations, but also about causation. He was barred, however, from testifying that the foreign body was SurgiWrap “as he has no basis for that testimony.” Id.

With respect to Dr. Brown’s testimony, the court determined that it was lay testimony and noted that he had admitted that “he did not know what caused the perforation” in Ms.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Cite This Page — Counsel Stack

Bluebook (online)
644 F.3d 1312, 85 Fed. R. Serv. 952, 2011 U.S. App. LEXIS 13362, 2011 WL 2566426, Counsel Stack Legal Research, https://law.counselstack.com/opinion/williams-v-mast-biosurgery-usa-inc-ca11-2011.